{
  "docId": "019de071-67f9-727e-bc6c-51745a3c53ca",
  "docSlug": "89984315105a6609dc5e897dea039740",
  "documentTitle": "Ginkgo | Results Presentation Deck | 30 slides",
  "authorId": "ginkgo",
  "authorName": "Ginkgo Bioworks",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 30,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "other",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "Includes a citation from Scientific American and a summary of the collaboration goals and progress.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de071-67f9-727e-bc6c-51745a3c53ca/19",
  "deckHref": "/decks/019de071-67f9-727e-bc6c-51745a3c53ca",
  "deckJsonHref": "/decks/019de071-67f9-727e-bc6c-51745a3c53ca.json",
  "deckAnchorHref": "/decks/019de071-67f9-727e-bc6c-51745a3c53ca#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.428,
        "x": 0.04,
        "y": 0.83
      },
      "kind": "callout",
      "text": "Aldevron collaboration dramatically improves availability and cost of Vaccinia Capping Enzyme (VCE), enabling it to be used in support of more therapies and doses",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a6f9a168-e01c-4e2f-b292-323a6097e714",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.13,
        "x": 0.805,
        "y": 0.1
      },
      "kind": "image",
      "text": "Aldevron",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70dbcc9b-6783-4551-8905-64db9e26b09d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.428,
        "x": 0.04,
        "y": 0.3
      },
      "kind": "list",
      "text": "Modality yields faster time to market and strong performance. Pfizer + Moderna are expected to produce 4-6 billion doses annually for COVID-19. Large pipeline of population-scale mRNA vaccines in development.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d880fbe-ea4b-48b6-ae37-d02059afb15e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.428,
        "x": 0.04,
        "y": 0.62
      },
      "kind": "list",
      "text": "Prior to COVID, mRNA modality was experimental. Several key components have become bottlenecked.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecb5c02f-b3de-4ba8-adaf-53dcece36664",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.428,
        "x": 0.04,
        "y": 0.24
      },
      "kind": "paragraph",
      "text": "mRNA Supply Chain is Expanding",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c7e4b1a9-60e9-419d-b756-0d0ac2a4a500",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.5,
        "x": 0.46,
        "y": 0.23
      },
      "kind": "quote",
      "text": "New COVID Vaccines Need Absurd Amounts of Material and Labor",
      "attrs": null,
      "subkind": "pull-quote",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c74e7afa-9332-4297-b428-d36666e9518c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.54,
        "x": 0.44,
        "y": 0.7
      },
      "kind": "table",
      "text": "Partner: Aldevron. Program Goals: Engineer organism and create new manufacturing process. Progress to Date: Completed program and yielded >10x improvement.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8f006ce5-64ec-4aa5-9080-2ad1987f2187",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.65,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "New partnership with Aldevron has potential to generate substantial near-term royalties",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2266a153-7693-45a0-bcc7-0e6645e9df88",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Aha! Moment",
      "slug": "aha-moment",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "ff427163-216b-4abe-af03-340ff972ffbd",
      "evidence": "quote/pull-quote: New COVID Vaccines Need Absurd Amounts of Material and Labor",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 22,
      "from": 15,
      "beatId": "e62a2e67-7e9c-4302-b9f0-5a4bd8c0f53a",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "The Breakthrough",
      "beatSlug": "rags-to-riches-the-breakthrough",
      "evidence": "The document showcases Ginkgo Bioworks' partnerships and collaborations, driving growth and innovation.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}